![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
![biaoTi](/_nuxt/img/biaoTi.0d1dc71.webp)
Part 1
Part 2
Part 3
Part 5
Guanfacine Extended-Release Pill is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. Guanfacine Extended-Release Pill report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Guanfacine Extended-Release Pill market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Inattention in Children and Children's Emotional Impulse are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Guanfacine Extended-Release Pill industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. Globally, Guanfacine Extended-Release Pill key manufacturers include TWi Pharmaceuticals USA, Inc., Shire Pharmaceuticals, APOTEX and TEVA Generics, etc. TWi Pharmaceuticals USA, Inc., Shire Pharmaceuticals, APOTEX are top 3 players and held % sales share in total in 2022. Guanfacine Extended-Release Pill can be divided into 1mg/Pill and 2mg/Pill, etc. 1mg/Pill is the mainstream product in the market, accounting for % sales share globally in 2022. Guanfacine Extended-Release Pill is widely used in various fields, such as Inattention in Children and Children's Emotional Impulse, etc. Inattention in Children provides greatest supports to the Guanfacine Extended-Release Pill industry development. In 2022, global % sales of Guanfacine Extended-Release Pill went into Inattention in Children filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Guanfacine Extended-Release Pill market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company TWi Pharmaceuticals USA, Inc. Shire Pharmaceuticals APOTEX TEVA Generics Segment by Type 1mg/Pill 2mg/Pill Segment by Application Inattention in Children Children's Emotional Impulse Segment by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE Each chapter of the report provides detailed information for readers to understand the Guanfacine Extended-Release Pill market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Guanfacine Extended-Release Pill, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Guanfacine Extended-Release Pill industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Guanfacine Extended-Release Pill in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Guanfacine Extended-Release Pill introduction, etc. Guanfacine Extended-Release Pill Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Guanfacine Extended-Release Pill market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
1 Guanfacine Extended-Release Pill Market Overview
1.1 Guanfacine Extended-Release Pill Product Overview
1.2 Guanfacine Extended-Release Pill Market Segment by Type
1.2.1 1mg/Pill
1.2.2 2mg/Pill
1.3 Global Guanfacine Extended-Release Pill Market Size by Type
1.3.1 Global Guanfacine Extended-Release Pill Market Size Overview by Type (2018-2029)
1.3.2 Global Guanfacine Extended-Release Pill Historic Market Size Review by Type (2018-2023)
1.3.3 Global Guanfacine Extended-Release Pill Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Guanfacine Extended-Release Pill Sales Breakdown by Type (2018-2023)
1.4.2 Europe Guanfacine Extended-Release Pill Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Guanfacine Extended-Release Pill Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Guanfacine Extended-Release Pill Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Guanfacine Extended-Release Pill Sales Breakdown by Type (2018-2023)2 Global Guanfacine Extended-Release Pill Market Competition by Company
2.1 Global Top Players by Guanfacine Extended-Release Pill Sales (2018-2023)
2.2 Global Top Players by Guanfacine Extended-Release Pill Revenue (2018-2023)
2.3 Global Top Players by Guanfacine Extended-Release Pill Price (2018-2023)
2.4 Global Top Manufacturers Guanfacine Extended-Release Pill Manufacturing Base Distribution, Sales Area, Product Type
2.5 Guanfacine Extended-Release Pill Market Competitive Situation and Trends
2.5.1 Guanfacine Extended-Release Pill Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Guanfacine Extended-Release Pill Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Guanfacine Extended-Release Pill as of 2022)
2.7 Date of Key Manufacturers Enter into Guanfacine Extended-Release Pill Market
2.8 Key Manufacturers Guanfacine Extended-Release Pill Product Offered
2.9 Mergers & Acquisitions, Expansion3 Guanfacine Extended-Release Pill Status and Outlook by Region
3.1 Global Guanfacine Extended-Release Pill Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Guanfacine Extended-Release Pill Historic Market Size by Region
3.2.1 Global Guanfacine Extended-Release Pill Sales in Volume by Region (2018-2023)
3.2.2 Global Guanfacine Extended-Release Pill Sales in Value by Region (2018-2023)
3.2.3 Global Guanfacine Extended-Release Pill Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Guanfacine Extended-Release Pill Forecasted Market Size by Region
3.3.1 Global Guanfacine Extended-Release Pill Sales in Volume by Region (2024-2029)
3.3.2 Global Guanfacine Extended-Release Pill Sales in Value by Region (2024-2029)
3.3.3 Global Guanfacine Extended-Release Pill Sales (Volume & Value), Price and Gross Margin (2024-2029)4 Global Guanfacine Extended-Release Pill by Application
4.1 Guanfacine Extended-Release Pill Market Segment by Application
4.1.1 Inattention in Children
4.1.2 Children's Emotional Impulse
4.2 Global Guanfacine Extended-Release Pill Market Size by Application
4.2.1 Global Guanfacine Extended-Release Pill Market Size Overview by Application (2018-2029)
4.2.2 Global Guanfacine Extended-Release Pill Historic Market Size Review by Application (2018-2023)
4.2.3 Global Guanfacine Extended-Release Pill Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Guanfacine Extended-Release Pill Sales Breakdown by Application (2018-2023)
4.3.2 Europe Guanfacine Extended-Release Pill Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Guanfacine Extended-Release Pill Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Guanfacine Extended-Release Pill Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Guanfacine Extended-Release Pill Sales Breakdown by Application (2018-2023)5 North America Guanfacine Extended-Release Pill by Country
5.1 North America Guanfacine Extended-Release Pill Historic Market Size by Country
5.1.1 North America Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Guanfacine Extended-Release Pill Sales in Volume by Country (2018-2023)
5.1.3 North America Guanfacine Extended-Release Pill Sales in Value by Country (2018-2023)
5.2 North America Guanfacine Extended-Release Pill Forecasted Market Size by Country
5.2.1 North America Guanfacine Extended-Release Pill Sales in Volume by Country (2024-2029)
5.2.2 North America Guanfacine Extended-Release Pill Sales in Value by Country (2024-2029)6 Europe Guanfacine Extended-Release Pill by Country
6.1 Europe Guanfacine Extended-Release Pill Historic Market Size by Country
6.1.1 Europe Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Guanfacine Extended-Release Pill Sales in Volume by Country (2018-2023)
6.1.3 Europe Guanfacine Extended-Release Pill Sales in Value by Country (2018-2023)
6.2 Europe Guanfacine Extended-Release Pill Forecasted Market Size by Country
6.2.1 Europe Guanfacine Extended-Release Pill Sales in Volume by Country (2024-2029)
6.2.2 Europe Guanfacine Extended-Release Pill Sales in Value by Country (2024-2029)7 Asia-Pacific Guanfacine Extended-Release Pill by Region
7.1 Asia-Pacific Guanfacine Extended-Release Pill Historic Market Size by Region
7.1.1 Asia-Pacific Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Guanfacine Extended-Release Pill Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Guanfacine Extended-Release Pill Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Guanfacine Extended-Release Pill Forecasted Market Size by Region
7.2.1 Asia-Pacific Guanfacine Extended-Release Pill Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Guanfacine Extended-Release Pill Sales in Value by Region (2024-2029)8 Latin America Guanfacine Extended-Release Pill by Country
8.1 Latin America Guanfacine Extended-Release Pill Historic Market Size by Country
8.1.1 Latin America Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Guanfacine Extended-Release Pill Sales in Volume by Country (2018-2023)
8.1.3 Latin America Guanfacine Extended-Release Pill Sales in Value by Country (2018-2023)
8.2 Latin America Guanfacine Extended-Release Pill Forecasted Market Size by Country
8.2.1 Latin America Guanfacine Extended-Release Pill Sales in Volume by Country (2024-2029)
8.2.2 Latin America Guanfacine Extended-Release Pill Sales in Value by Country (2024-2029)9 Middle East and Africa Guanfacine Extended-Release Pill by Country
9.1 Middle East and Africa Guanfacine Extended-Release Pill Historic Market Size by Country
9.1.1 Middle East and Africa Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Guanfacine Extended-Release Pill Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Guanfacine Extended-Release Pill Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Guanfacine Extended-Release Pill Forecasted Market Size by Country
9.2.1 Middle East and Africa Guanfacine Extended-Release Pill Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Guanfacine Extended-Release Pill Sales in Value by Country (2024-2029)10 Company Profiles
10.1 TWi Pharmaceuticals USA, Inc.
10.1.1 TWi Pharmaceuticals USA, Inc. Company Information
10.1.2 TWi Pharmaceuticals USA, Inc. Introduction and Business Overview
10.1.3 TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Sales, Revenue and Gross Margin (2018-2023)
10.1.4 TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Products Offered
10.1.5 TWi Pharmaceuticals USA, Inc. Recent Development
10.2 Shire Pharmaceuticals
10.2.1 Shire Pharmaceuticals Company Information
10.2.2 Shire Pharmaceuticals Introduction and Business Overview
10.2.3 Shire Pharmaceuticals Guanfacine Extended-Release Pill Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Shire Pharmaceuticals Guanfacine Extended-Release Pill Products Offered
10.2.5 Shire Pharmaceuticals Recent Development
10.3 APOTEX
10.3.1 APOTEX Company Information
10.3.2 APOTEX Introduction and Business Overview
10.3.3 APOTEX Guanfacine Extended-Release Pill Sales, Revenue and Gross Margin (2018-2023)
10.3.4 APOTEX Guanfacine Extended-Release Pill Products Offered
10.3.5 APOTEX Recent Development
10.4 TEVA Generics
10.4.1 TEVA Generics Company Information
10.4.2 TEVA Generics Introduction and Business Overview
10.4.3 TEVA Generics Guanfacine Extended-Release Pill Sales, Revenue and Gross Margin (2018-2023)
10.4.4 TEVA Generics Guanfacine Extended-Release Pill Products Offered
10.4.5 TEVA Generics Recent Development11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Guanfacine Extended-Release Pill Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Guanfacine Extended-Release Pill Industrial Chain Analysis
11.4 Guanfacine Extended-Release Pill Market Dynamics
11.4.1 Guanfacine Extended-Release Pill Industry Trends
11.4.2 Guanfacine Extended-Release Pill Market Drivers
11.4.3 Guanfacine Extended-Release Pill Market Challenges
11.4.4 Guanfacine Extended-Release Pill Market Restraints12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Guanfacine Extended-Release Pill Distributors
12.3 Guanfacine Extended-Release Pill Downstream Customers13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables Table 1. Major Company of 1mg/Pill Table 2. Major Company of 2mg/Pill Table 3. Global Guanfacine Extended-Release Pill Sales by Type 2018 VS 2022 VS 2029 (US$ Million) Table 4. Global Guanfacine Extended-Release Pill Sales by Type (2018-2023) & (K Units) Table 5. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Type (2018-2023) Table 6. Global Guanfacine Extended-Release Pill Sales by Type (2018-2023) & (US& Million) Table 7. Global Guanfacine Extended-Release Pill Market Share in Value by Type (2018-2023) Table 8. Global Guanfacine Extended-Release Pill Price by Type (2018-2023) & (US$/Unit) Table 9. Global Guanfacine Extended-Release Pill Sales by Type (2024-2029) & (K Units) Table 10. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Type (2024-2029) Table 11. Global Guanfacine Extended-Release Pill Sales by Type (2024-2029) & (US$ Million) Table 12. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Type (2024-2029) Table 13. Global Guanfacine Extended-Release Pill Price by Type (2024-2029) & (US$/Unit) Table 14. North America Guanfacine Extended-Release Pill Sales by Type (2018-2023) & (K Units) Table 15. North America Guanfacine Extended-Release Pill Sales by Type (2018-2023) & (US$ Million) Table 16. Europe Guanfacine Extended-Release Pill Sales (K Units) by Type (2018-2023) Table 17. Europe Guanfacine Extended-Release Pill Sales by Type (2018-2023) & (US$ Million) Table 18. Asia-Pacific Guanfacine Extended-Release Pill Sales (K Units) by Type (2018-2023) Table 19. Asia-Pacific Guanfacine Extended-Release Pill Sales by Type (2018-2023) & (US$ Million) Table 20. Latin America Guanfacine Extended-Release Pill Sales (K Units) by Type (2018-2023) Table 21. Latin America Guanfacine Extended-Release Pill Sales by Type (2018-2023) & (US$ Million) Table 22. Middle East and Africa Guanfacine Extended-Release Pill Sales (K Units) by Type (2018-2023) Table 23. Middle East and Africa Guanfacine Extended-Release Pill Sales by Type (2018-2023) & (US$ Million) Table 24. Global Guanfacine Extended-Release Pill Sales by Company (2018-2023) & (K Units) Table 25. Global Guanfacine Extended-Release Pill Sales Share by Company (2018-2023) Table 26. Global Guanfacine Extended-Release Pill Revenue by Company (2018-2023) & (US$ Million) Table 27. Global Guanfacine Extended-Release Pill Revenue Share by Company (2018-2023) Table 28. Global Market Guanfacine Extended-Release Pill Price by Company (2018-2023) & (US$/Unit) Table 29. Global Guanfacine Extended-Release Pill Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Guanfacine Extended-Release Pill Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Guanfacine Extended-Release Pill as of 2022) Table 32. Date of Key Manufacturers Enter into Guanfacine Extended-Release Pill Market Table 33. Key Manufacturers Guanfacine Extended-Release Pill Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Guanfacine Extended-Release Pill Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029 Table 36. Global Guanfacine Extended-Release Pill Sales by Region (2018-2023) & (K Units) Table 37. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Region (2018-2023) Table 38. Global Guanfacine Extended-Release Pill Sales by Region (2018-2023) & (US$ Million) Table 39. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Region (2018-2023) Table 40. Global Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 41. Global Guanfacine Extended-Release Pill Sales by Region (2024-2029) & (K Units) Table 42. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Region (2024-2029) Table 43. Global Guanfacine Extended-Release Pill Sales by Region (2024-2029) & (US$ Million) Table 44. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Region (2024-2029) Table 45. Global Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029) Table 46. Global Guanfacine Extended-Release Pill Sales by Application: 2018 VS 2022 VS 2029 (US$ Million) Table 47. Global Guanfacine Extended-Release Pill Sales by Application (2018-2023) & (K Units) Table 48. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Application (2018-2023) Table 49. Global Guanfacine Extended-Release Pill Sales by Application (2018-2023) & (US$ Million) Table 50. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Application (2018-2023) Table 51. Global Guanfacine Extended-Release Pill Price by Application (2018-2023) & (US$/Unit) Table 52. Global Guanfacine Extended-Release Pill Sales by Application (2024-2029) & (K Units) Table 53. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Application (2024-2029) Table 54. Global Guanfacine Extended-Release Pill Sales by Application (2024-2029) & (US$ Million) Table 55. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Application (2024-2029) Table 56. Global Guanfacine Extended-Release Pill Price by Application (2024-2029) & (US$/Unit) Table 57. North America Guanfacine Extended-Release Pill Sales by Application (2018-2023) (K Units) Table 58. North America Guanfacine Extended-Release Pill Sales by Application (2018-2023) & (US$ Million) Table 59. Europe Guanfacine Extended-Release Pill Sales by Application (2018-2023) (K Units) Table 60. Europe Guanfacine Extended-Release Pill Sales by Application (2018-2023) & (US$ Million) Table 61. Asia-Pacific Guanfacine Extended-Release Pill Sales by Application (2018-2023) (K Units) Table 62. Asia-Pacific Guanfacine Extended-Release Pill Sales by Application (2018-2023) & (US$ Million) Table 63. Latin America Guanfacine Extended-Release Pill Sales by Application (2018-2023) (K Units) Table 64. Latin America Guanfacine Extended-Release Pill Sales by Application (2018-2023) & (US$ Million) Table 65. Middle East and Africa Guanfacine Extended-Release Pill Sales by Application (2018-2023) (K Units) Table 66. Middle East and Africa Guanfacine Extended-Release Pill Sales by Application (2018-2023) & (US$ Million) Table 67. North America Guanfacine Extended-Release Pill Sales by Country (2018-2023) & (K Units) Table 68. North America Guanfacine Extended-Release Pill Sales Market Share in Volume by Country (2018-2023) Table 69. North America Guanfacine Extended-Release Pill Sales by Country (2018-2023) & (US$ Million) Table 70. North America Guanfacine Extended-Release Pill Sales Market Share in Value by Country (2018-2023) Table 71. North America Guanfacine Extended-Release Pill Sales by Country (2024-2029) & (K Units) Table 72. North America Guanfacine Extended-Release Pill Sales Market Share in Volume by Country (2024-2029) Table 73. North America Guanfacine Extended-Release Pill Sales by Country (2024-2029) & (US$ Million) Table 74. North America Guanfacine Extended-Release Pill Sales Market Share in Value by Country (2024-2029) Table 75. Europe Guanfacine Extended-Release Pill Sales by Country (2018-2023) & (K Units) Table 76. Europe Guanfacine Extended-Release Pill Sales Market Share in Volume by Country (2018-2023) Table 77. Europe Guanfacine Extended-Release Pill Sales by Country (2018-2023) & (US$ Million) Table 78. Europe Guanfacine Extended-Release Pill Sales Market Share in Value by Country (2018-2023) Table 79. Europe Guanfacine Extended-Release Pill Sales by Country (2024-2029) & (K Units) Table 80. Europe Guanfacine Extended-Release Pill Sales Market Share in Volume by Country (2024-2029) Table 81. Europe Guanfacine Extended-Release Pill Sales by Country (2024-2029) & (US$ Million) Table 82. Europe Guanfacine Extended-Release Pill Sales Market Share in Value by Country (2024-2029) Table 83. Asia-Pacific Guanfacine Extended-Release Pill Sales by Region (2018-2023) & (K Units) Table 84. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Volume by Region (2018-2023) Table 85. Asia-Pacific Guanfacine Extended-Release Pill Sales by Region (2018-2023) & (US$ Million) Table 86. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Value by Region (2018-2023) Table 87. Asia-Pacific Guanfacine Extended-Release Pill Sales by Region (2024-2029) & (K Units) Table 88. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Volume by Region (2024-2029) Table 89. Asia-Pacific Guanfacine Extended-Release Pill Sales by Region (2024-2029) & (US$ Million) Table 90. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Value by Region (2024-2029) Table 91. Latin America Guanfacine Extended-Release Pill Sales by Country (2018-2023) & (K Units) Table 92. Latin America Guanfacine Extended-Release Pill Sales Market Share in Volume by Country (2018-2023) Table 93. Latin America Guanfacine Extended-Release Pill Sales by Country (2018-2023) & (US$ Million) Table 94. Latin America Guanfacine Extended-Release Pill Sales Market Share in Value by Country (2018-2023) Table 95. Latin America Guanfacine Extended-Release Pill Sales by Country (2024-2029) & (K Units) Table 96. Latin America Guanfacine Extended-Release Pill Sales Market Share in Volume by Country (2024-2029) Table 97. Latin America Guanfacine Extended-Release Pill Sales by Country (2024-2029) & (US$ Million) Table 98. Latin America Guanfacine Extended-Release Pill Sales Market Share in Value by Country (2024-2029) Table 99. Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2018-2023) & (K Units) Table 100. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Volume by Country (2018-2023) Table 101. Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2018-2023) & (US$ Million) Table 102. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Value by Country (2018-2023) Table 103. Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2024-2029) & (K Units) Table 104. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Volume by Country (2024-2029) Table 105. Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2024-2029) & (US$ Million) Table 106. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Value by Country (2024-2029) Table 107. TWi Pharmaceuticals USA, Inc. Company Information Table 108. TWi Pharmaceuticals USA, Inc. Introduction and Business Overview Table 109. TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 110. TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Product Table 111. TWi Pharmaceuticals USA, Inc. Recent Development Table 112. Shire Pharmaceuticals Company Information Table 113. Shire Pharmaceuticals Introduction and Business Overview Table 114. Shire Pharmaceuticals Guanfacine Extended-Release Pill Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 115. Shire Pharmaceuticals Guanfacine Extended-Release Pill Product Table 116. Shire Pharmaceuticals Recent Development Table 117. APOTEX Company Information Table 118. APOTEX Introduction and Business Overview Table 119. APOTEX Guanfacine Extended-Release Pill Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 120. APOTEX Guanfacine Extended-Release Pill Product Table 121. APOTEX Recent Development Table 122. TEVA Generics Company Information Table 123. TEVA Generics Introduction and Business Overview Table 124. TEVA Generics Guanfacine Extended-Release Pill Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023) Table 125. TEVA Generics Guanfacine Extended-Release Pill Product Table 126. TEVA Generics Recent Development Table 127. Key Raw Materials Lists Table 128. Raw Materials Key Suppliers Lists Table 129. Guanfacine Extended-Release Pill Market Trends Table 130. Guanfacine Extended-Release Pill Market Drivers Table 131. Guanfacine Extended-Release Pill Market Challenges Table 132. Guanfacine Extended-Release Pill Market Restraints Table 133. Guanfacine Extended-Release Pill Distributors List Table 134. Guanfacine Extended-Release Pill Downstream Customers Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Guanfacine Extended-Release Pill Product Picture Figure 2. Global Guanfacine Extended-Release Pill Market Size, 2018 VS 2022 VS 2029 (US$ Million) Figure 3. Global Guanfacine Extended-Release Pill Market Size Status and Outlook (2018-2029) & (US$ Million) Figure 4. Global Guanfacine Extended-Release Pill Sales Status and Outlook (2018-2029) & (K Units) Figure 5. Product Picture of 1mg/Pill Figure 6. Global 1mg/Pill Sales YoY Growth (2018-2029) & (K Units) Figure 7. Product Picture of 2mg/Pill Figure 8. Global 2mg/Pill Sales YoY Growth (2018-2029) & (K Units) Figure 9. Global Guanfacine Extended-Release Pill Sales by Type (2018-2029) & (US$ Million) Figure 10. Global Guanfacine Extended-Release Pill Sales Market Share by Type in 2022 & 2029 Figure 11. North America Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2022 Figure 12. North America Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2022 Figure 13. Europe Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2022 Figure 14. Europe Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2022 Figure 15. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2022 Figure 16. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2022 Figure 17. Latin America Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2022 Figure 18. Latin America Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2022 Figure 19. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2022 Figure 20. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2022 Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Guanfacine Extended-Release Pill Sales in 2022 Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Guanfacine Extended-Release Pill Revenue in 2022 Figure 23. Guanfacine Extended-Release Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022 Figure 24. Product Picture of Inattention in Children Figure 25. Global Inattention in Children Sales YoY Growth (2018-2029) & (K Units) Figure 26. Product Picture of Children's Emotional Impulse Figure 27. Global Children's Emotional Impulse Sales YoY Growth (2018-2029) & (K Units) Figure 28. Global Guanfacine Extended-Release Pill Sales by Application (2018-2029) & (US$ Million) Figure 29. Global Guanfacine Extended-Release Pill Sales Market Share by Application in 2022 & 2029 Figure 30. North America Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2022 Figure 31. North America Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2022 Figure 32. Europe Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2022 Figure 33. Europe Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2022 Figure 34. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2022 Figure 35. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2022 Figure 36. Latin America Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2022 Figure 37. Latin America Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2022 Figure 38. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2022 Figure 39. Key Raw Materials Price Figure 40. Guanfacine Extended-Release Pill Manufacturing Cost Structure Figure 41. Guanfacine Extended-Release Pill Industrial Chain Analysis Figure 42. Channels of Distribution Figure 43. Distributors Profiles Figure 44. Bottom-up and Top-down Approaches for This Report Figure 45. Data Triangulation Figure 46. Key Executives Interviewed
Guanfacine Extended-Release Pill is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years. Guanfacine Extended-Release Pill report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Guanfacine Extended-Release Pill market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Inattention in Children and Children's Emotional Impulse are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Guanfacine Extended-Release Pill industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. Globally, Guanfacine Extended-Release Pill key manufacturers include TWi Pharmaceuticals USA, Inc., Shire Pharmaceuticals, APOTEX and TEVA Generics, etc. TWi Pharmaceuticals USA, Inc., Shire Pharmaceuticals, APOTEX are top 3 players and held % sales share in total in 2022. Guanfacine Extended-Release Pill can be divided into 1mg/Pill and 2mg/Pill, etc. 1mg/Pill is the mainstream product in the market, accounting for % sales share globally in 2022. Guanfacine Extended-Release Pill is widely used in various fields, such as Inattention in Children and Children's Emotional Impulse, etc. Inattention in Children provides greatest supports to the Guanfacine Extended-Release Pill industry development. In 2022, global % sales of Guanfacine Extended-Release Pill went into Inattention in Children filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Guanfacine Extended-Release Pill market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company TWi Pharmaceuticals USA, Inc. Shire Pharmaceuticals APOTEX TEVA Generics Segment by Type 1mg/Pill 2mg/Pill Segment by Application Inattention in Children Children's Emotional Impulse Segment by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE Each chapter of the report provides detailed information for readers to understand the Guanfacine Extended-Release Pill market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Guanfacine Extended-Release Pill, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Guanfacine Extended-Release Pill industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Guanfacine Extended-Release Pill in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Guanfacine Extended-Release Pill introduction, etc. Guanfacine Extended-Release Pill Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Guanfacine Extended-Release Pill market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
USD 3350.00
USD 5025.00
USD 6700.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now